Interestingly, we found reduced levels of ADARB1 and ADARB2 in glioma samples, indicating that these two ADAR family enzymes may play an important role in A-to-I RNA editing events in glioma (Figs. S8A, S8C and S8D). Here, ADARB1 is linked to central nervous system cancer.